Trial Approaching in Nexium Antitrust Class Action Lawsuit

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Litigation surrounding the alleged delayal of less expensive generic versions of Nexium (esomeprazole magnesium) by several pharmaceutical companies continues to progress in federal court. If the parties are unable to reach a class action settlement, the Nexium antitrust lawsuit will go to trial on March 3, 2014.

The case affects everyone nationwide who purchased Nexium as a consumer or a third-party payor. A separate Nexium class action settlement was reached in 2012 involving only Massachusetts consumers.

The class action lawsuit is about the price of Nexium and whether its manufacturer AstraZeneca delayed the availability of a cheaper generic version through anticompetitive agreements with potential generic Nexium manufacturers Ranbaxy, Teva and Dr. Reddy’s. The plaintiffs allege that the defendants entered into unlawful settlements of patent lawsuits. They claim these actions denied end-payors who paid for Nexium the benefits of competition and forced them to pay higher prices than they otherwise would have paid.

The defendants deny the allegations, asserting that the settlements of patent lawsuits did not violate antitrust laws and that their actions have not delayed the entry of generic Nexium products into the market.

The Nexium lawsuit was certified as a class action lawsuit on Nov. 14, 2013. Two classes have been certified: a consumer class and a third-party payor class.

You are a Consumer Class Member if you purchased or paid for some or all of the purchase price for Nexium and/or its generic equivalent in capsule form for consumption by yourself or your family. The specific class period depends on the state in which you purchased the product. Not all states are involved in this class action lawsuit. Click here for more detailed information about the characteristics of the Consumer Class.

You are a Third-Party Payor Class Member if you purchased or paid for some or all of the purchase price for Nexium and/or its generic equivalent in capsule form for consumption by your members, employees, insured, participants or beneficiaries. The specific class period varies by state, and not all states are involved in the class action lawsuit. Click here for more information about the Third-Party Payor Class characteristics.

For more information about the Nexium class action lawsuit, visit www.NexiumCase.com. Top Class Actions will update readers about how to file a claim if a class action settlement is reached. Keep checking our website or sign up for the newsletter below to get the latest updates.

Class Members are represented by Steve D. Shadowen of Hilliard & Shadowen LLC, Kenneth A. Wexler of Wexler Wallace LLP, J. Douglas Richards of Cohen Milstein Sellers & Toll PLLC and Jayne A. Goldstein of Pomerantz Grossman Hufford Dahlstrom & Gross LLP.

The Nexium Antitrust Class Action Lawsuit is In re: Nexium Antitrust Litigation, Case No. 1:12-cv-02409-WYG, in the U.S. District Court for the District of Massachusetts.